Skip to content

The differences in blood glucose management and affects on cardiac function of SGLT2 and DPP4 inhibitors

The differences in blood glucose management and affects on cardiac function of SGLT2 and DPP4 inhibitors - The differences between SGLT2 and DPP4 inhibitors in cardiac function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000032272
Enrollment
60
Registered
2018-04-20
Start date
2018-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus (DM) patients complicated with heart failure preserved ejection fraction (HFpEF)

Interventions

If blood glucose management with patients who were administrated with DPP4 inhibitor were more bad, strict diet exercise therapy is performed and DPP4 inhibitor is continued. DPP4 inhibitors or SGLT

Sponsors

Toho University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Outpatients with DM and HFpEF of NHYA classification of I - III Medications (including DPP4 inhibitor) did not changed of dosage before 4 weeks from examincation start Blood glucose management were worsening and patients who need to strict diet/exercise therapy or change medication.

Exclusion criteria

Exclusion criteria: Pregnancy, breast-feeding, patients who may be pregnant, and patients who want pregnancy during the examination Patients who may be thought to worse blood glucose management with the protocol of this examination. Patients who are received with DPP 4 inhibitor, once a week. Patients with moderate or severe renal impairment (less than eGFR 45) Patients with severe hepatic impairment (Child-Pugh classification C) Patients who were judged inappropriate as subjects of this examination by investigators

Design outcomes

Primary

MeasureTime frame
Presence or absence of total/cardiovascular death, re-hospitalization of HF and worsening of DM

Countries

Japan

Contacts

Public ContactShunsuke Kiuchi

Toho University Omori Medical Center Department of Cardiovascular Medicine

syunnsuke@med.toho-u.ac.jp03-3762-4151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026